|
PLK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57651669496772E-14 |
| Normal-vs-Stage2 |
2.999300E-03 |
| Normal-vs-Stage3 |
4.65100000002217E-06 |
| Normal-vs-Stage4 |
1.286370E-02 |
| Stage1-vs-Stage2 |
8.271400E-01 |
| Stage1-vs-Stage3 |
4.649500E-04 |
| Stage1-vs-Stage4 |
4.976100E-02 |
| Stage2-vs-Stage3 |
1.038970E-03 |
| Stage2-vs-Stage4 |
5.725700E-02 |
| Stage3-vs-Stage4 |
9.664000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.00860000018521E-07 |
| Normal-vs-Asian |
3.770400E-02 |
| Caucasian-vs-AfricanAmerican |
1.796170E-01 |
| Caucasian-vs-Asian |
5.548600E-01 |
| AfricanAmerican-vs-Asian |
1.925220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.23229999537955E-08 |
| Male-vs-Female |
8.543700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.47839999999844E-05 |
| Normal-vs-Extreme_Weight |
1.13720000083362E-09 |
| Normal-vs-Obese |
5.45430001164249E-09 |
| Normal-vs-Extreme_Obese |
8.137400E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.491580E-01 |
| Normal_Weight-vs-Obese |
8.577200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.521900E-02 |
| Extreme_Weight-vs-Obese |
7.250100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.856300E-02 |
| Obese-vs-Extreme_Obese |
2.203000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.57340000000295E-05 |
| Normal-vs-Age(41-60Yrs) |
2.06745731645697E-12 |
| Normal-vs-Age(61-80Yrs) |
7.9586004453347E-11 |
| Normal-vs-Age(81-100Yrs) |
1.479310E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.473400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.473900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.108500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.211770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.670500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.136600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
4.84359999997075E-07 |
| Normal-VS-KIRP CIMP |
5.061400E-03 |
| Normal-VS-Unclassified PRCC |
1.027290E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.149600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.374100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.468100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.415900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.583600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.142100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.82549999969839E-07 |
| Normal-vs-N1 |
4.16449999995905E-06 |
| Normal-vs-N2 |
1.253230E-01 |
| N0-vs-N1 |
1.256570E-03 |
| N0-vs-N2 |
2.327800E-01 |
| N1-vs-N2 |
7.464400E-01 |
|
|
